These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3427836)

  • 1. Renal hemodynamics, converting enzyme inhibitors and calcium antagonists in atheromatous renovascular hypertension.
    Hannedouche T; Godin M; Fillastre JP
    Clin Nephrol; 1987 Nov; 28(5):261-2. PubMed ID: 3427836
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibition and renal insufficiency in patients with bilateral renovascular disease.
    Dominiczak A; Isles C; Gillen G; Brown JJ
    J Hum Hypertens; 1988 Jun; 2(1):53-6. PubMed ID: 3070034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal protective effects of calcium antagonists].
    Musialik D; Raszeja-Wanic B; Tylarski A
    Pol Merkur Lekarski; 1996 Oct; 1(4):266-70. PubMed ID: 9156942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug therapy of renovascular hypertension].
    Kusano E; Takeda S
    Nihon Rinsho; 1992 May; 50 Suppl():640-3. PubMed ID: 1355140
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progressive reversible kidney insufficiency after blood pressure reduction with captopril].
    Kindler J; Konrads A; Meurer KA; Sieberth HG
    Internist (Berl); 1981 Jun; 22(6):360-3. PubMed ID: 6265394
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal effects of angiotensin-I converting enzyme inhibitors.
    Gans RO; Hoorntje SJ; Donker AJ
    Neth J Med; 1988 Jun; 32(5-6):247-64. PubMed ID: 3292962
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcium antagonists and the kidney.
    Epstein M
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S18-24. PubMed ID: 7603073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Angiotensin-converting enzyme inhibitors and acute renal failure].
    Rozin A
    Harefuah; 1998 Sep; 135(5-6):239-43. PubMed ID: 9885645
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of renin-angiotensin to calcium channel blockade in renal disease.
    Tikkanen I; Johnston CI
    Kidney Int Suppl; 1997 Dec; 63():S19-22. PubMed ID: 9407414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Learning experiences from UNC. Renal autoregulation, drugs, and acute renal failure.
    Blythe WB
    N C Med J; 1985 Jul; 46(7):413-4. PubMed ID: 2993929
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition in renovascular hypertension: the narrowing gap between functional renal failure and progressive renal atrophy.
    Hricik DE
    J Lab Clin Med; 1990 Jan; 115(1):8-9. PubMed ID: 2299259
    [No Abstract]   [Full Text] [Related]  

  • 15. [Renal function after administration of angiotensin-converting enzyme inhibitors].
    Waeber B; Burnier M; Nussberger J; Brunner HR
    Schweiz Med Wochenschr; 1987 Sep; 117(37):1359-62. PubMed ID: 3672075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin-converting enzyme inhibition and calcium channel blockade on cardiac apoptosis in rats with 2K1C (two-kidney/one-clip) renovascular hypertension.
    Thöne-Reineke C; Olivier J; Godes M; Zart R; George I; Bauer C; Neumayer HH; Hocher B
    Clin Sci (Lond); 2003 Jan; 104(1):79-85. PubMed ID: 12519090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic hypertension and antihypertensive agents.
    Maschio G; Marcantoni C; Bernich P
    J Nephrol; 1999; 12 Suppl 2():S100-4. PubMed ID: 10688408
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcium antagonists and renal failure progression.
    Robles NR
    Ren Fail; 2008; 30(3):247-55. PubMed ID: 18350443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural changes and cyclic GMP content of the aorta after calcium antagonism or angiotensin converting enzyme inhibition in renovascular hypertensive rats.
    Véniant M; Gray GA; Heudes D; Ménard J; Clozel JP
    J Hypertens; 1995 Jul; 13(7):731-7. PubMed ID: 7594436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ACE-inhibitors in renal protection].
    Barna I
    Orv Hetil; 2006 Jun; 147(22):1019-23. PubMed ID: 16913091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.